https://www.selleckchem.com/pr....oducts/gsk-lsd1-2hcl
ve PCI on the TAVI hospitalization period. The prognostic significance of CTO in the non-IRA in patients with AMI has been under dispute. Relevant long-term follow-up studies are lacking. . CTO in the non-IRA is an independent predictor of poor long-term prognosis in patients with AMI. We prospectively enrolled 2336 patients with AMI who received emergent percutaneous coronary intervention successfully from January 2006 to May 2011. Our primary endpoints included death from cardiovascular causes, recurrent myocardial infarction, s
Like
Comment
Share
